| B-16 Antari Khot Do tree-based machine learning methods outperform Cox regression for progression-free survival prediction in mobocertinib treated lung cancer patients? Wednesday 14:50-15:10 |
| C-09 Iñaki F. Trocóniz Modeling the dynamics of anti-drug antibodies in cancer patients treated with oncolytic virus in monotherapy or in combination with immune check- point inhibitors Thursday 11:45-12:05 |
| C-15 Yomna Nassar A joint tumour dynamics and C-reactive protein turnover model to identify early longitudinal prognostic predictors of overall survival in advanced non-small cell lung cancer patients Thursday 14:40-15:00 |
| C-16 Anna Kondic The combined use of propensity score matching and a joint tumor growth dynamics (TGD) - Overall Survival (OS) model to benchmark the efficacy of new treatments for advanced renal cell carcinoma (RCC) Thursday 15:00-15:20 |
| D-04 Robin Michelet Development and Application of a Minimal Physiology-based Pharmacokinetics Modelling Framework to Predict Tumor Penetration and Receptor Occupancy. Friday 9:55-10:15 |
